Moreover, PDE4D inhibitors (rolipram, roflumilast, and GEBR-7b) have been extensively studied for preventing inflammatory diseases and cancer cell tumor growth specifically in lung cancer and breast cancer (35, 52, 53, 55). This evidence concerns the gene PDE4D and lung carcinoma.